Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

37.87
+3.068.79%
Post-market: 37.78-0.0900-0.24%19:58 EDT
Volume:5.58M
Turnover:207.09M
Market Cap:4.38B
PE:-9.10
High:38.08
Open:35.63
Low:35.03
Close:34.81
52wk High:43.15
52wk Low:22.96
Shares:115.55M
Float Shares:110.00M
Volume Ratio:1.72
T/O Rate:5.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1600
EPS(LYR):-3.1920
ROE:-70.04%
ROA:-42.54%
PB:8.72
PE(LYR):-11.86

Loading ...

May 26, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 30, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Feb 11, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 22, 2025

Major Issues Report

Form 8-K - Current report
Aug 19, 2025

Major Issues Report

Form 8-K - Current report
Jul 23, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 23, 2025

Major Issues Report

Form 8-K - Current report
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities